Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Organization National Institutes of HealthPosted 4 May 2026Deadline 10 Nov 2026
HHS-NIH1193.853synopsis
Sign up free to applyFull description · apply link · all types
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Opportunity Number: RFA-NS-26-001 Document Type: synopsis CFDA Numbers: 93.853

Read the full description

Sign up freeFree account · No credit card required